Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 625095 57 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN115537405A reveals a novel ketoreductase mutant for high-purity (S)-1-(3-chlorophenyl)-1,3-propanediol production, offering significant cost reduction in API manufacturing.